GENERAL MILLS INC quarterly report, Q3 FY2024

General Mills, Inc. — Form 10-Q Summary

Reporting period: Fiscal third quarter ended February 25, 2024, and nine months ended February 25, 2024, compared with the corresponding 2023 periods. The filing metadata labels this “2023 Q3,” but the filing itself covers fiscal 2024 Q3.

Business context and results

General Mills is a packaged-foods company reporting four segments: North America Retail, International, Pet, and North America Foodservice.

  • Quarter: Net sales were $5.10 billion, down 1%. Organic sales also declined 1%: volume contributed negative 2 percentage points, partly offset by positive 2 points from price and mix. Operating profit rose 25% to $910.7 million; operating margin was 17.9%, up 370 basis points. Net earnings attributable to General Mills were $670.1 million, up 21%, and diluted EPS was $1.17, up 27%.
  • Nine months: Net sales were $15.14 billion, up 1%; organic sales rose 1%, with price and mix adding 4 points and volume subtracting 3. Operating profit increased 1% to $2.65 billion, with a 17.5% margin, up 10 basis points. Net earnings attributable to General Mills were $1.94 billion, down 2%; diluted EPS was $3.33, up 2%.
  • Adjusted performance (non-GAAP): Quarterly adjusted operating profit was $914.5 million, up 14% on a constant-currency basis, and adjusted diluted EPS was $1.17, up 22% on that basis. Nine-month adjusted operating profit was $2.80 billion, up 9% constant currency; adjusted diluted EPS was $3.51, up 11%.
  • Segment trends: In the quarter, North America Retail sales were flat and operating profit fell 4%; International sales fell 3% and operating profit fell 57%; Pet sales fell 3% while operating profit rose 25%; Foodservice sales rose 1% and operating profit fell 1%. Pet and International sales declines reflected weaker volume.

Cash flow, debt, and liquidity

  • Nine-month operating cash flow was $2.44 billion, versus $2.03 billion a year earlier. Capital spending was $485.6 million; operating cash flow less capital spending was approximately $1.95 billion.
  • Cash and cash equivalents were $588.6 million at February 25, 2024. Current assets were $4.65 billion and current liabilities $7.06 billion.
  • Long-term debt, including its current portion, was $11.83 billion; notes payable were $686.7 million, mainly U.S. commercial paper. The company issued $1.0 billion of long-term debt and repaid $900 million during the nine months. Interest expense, net, increased to $356.5 million from $277.5 million.
  • Financing cash outflows included $1.60 billion of share repurchases and $1.03 billion of dividends. The company reported $3.3 billion of committed and uncommitted credit facilities available and compliance with debt and credit covenants; management said expected operating cash flows and financing access would meet needs for at least 12 months.

Material changes and unusual items

  • Quarterly operating profit benefited from lower compensation and benefits expenses, favorable price and mix, improved commodity mark-to-market effects, and net recoveries related to the prior-year Häagen-Dazs product recall. Higher input costs and lower volume contributions partly offset these benefits.
  • Nine-month comparisons include a $444.6 million prior-year divestiture gain from the sale of the Helper and Suddenly Salad businesses. Fiscal 2024 included a $117.1 million non-cash goodwill impairment for the Latin America reporting unit, reflecting lower projected future profitability.
  • The company recorded $130.6 million of restructuring, impairment, and other exit costs in the nine-month period, versus $14.1 million a year earlier. Certain brand intangibles, including True Chews and Uncle Toby’s, were also identified as having limited impairment coverage; other named brands were flagged for monitoring.

Outlook, risks, and contingencies

  • Management expects approximately 4% input-cost inflation in fiscal 2024 and higher Holistic Margin Management cost savings than in fiscal 2023. It identified consumer economic health, moderating input-cost inflation, and supply-chain stability as important performance factors. The provided filing text does not state a specific full-year EPS forecast.
  • Key stated risks include consumer demand and response to pricing, competition, input-cost and supply-chain volatility, product quality and recalls, foreign exchange, interest rates, impairment risk, and the effectiveness of restructuring and cost-saving initiatives.
  • The company is contesting a proposed IRS adjustment related to a fiscal 2019 capital loss and said it does not expect a material effect on financial position or liquidity. It is also defending a São Paulo, Brazil sales-tax assessment; as of the filing date it could not estimate a possible loss and had recorded no loss contingency.
  • Commodity derivatives and certain grain inventories create mark-to-market earnings volatility. Supplier-financing services are available to suppliers at their discretion; $1.35 billion of accounts payable was owed to suppliers using those services at quarter-end. The company says it has no guarantee or direct financing relationship with the providers.

Important facts for investors to verify

  • Whether volume trends improve, especially in Pet and International, and whether price and mix can continue to offset weaker volumes and input costs.
  • How much reported and adjusted profit growth depends on nonrecurring items, including prior-year divestiture gains, recall recoveries, commodity mark-to-market changes, and the Latin America impairment.
  • Debt refinancing needs, interest costs, commercial-paper usage, and the company’s capacity to sustain substantial dividends and share repurchases.
  • Progress and expected cash costs of restructuring, and any subsequent impairment indicators for goodwill or brand intangibles.
  • Developments in the IRS and Brazil tax matters; the filing does not provide an estimated possible loss for the Brazil matter.